Neonc Technologies (NASDAQ:NTHI) Stock: Insider Amir Heshmatpour Purchases 50,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour acquired 50,000 shares of the stock in a transaction that occurred on Tuesday, November 10th. The stock was purchased at an average price of $4.19 per share, for a total transaction of $209,500.00. Following the completion of the acquisition, the chief executive officer owned 3,313,000 shares in the company, valued at $13,881,470. The trade was a 1.53% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Neonc Technologies Stock Up 3.4%

Shares of NASDAQ NTHI opened at $4.52 on Thursday. Neonc Technologies Holdings, Inc. has a 12-month low of $2.50 and a 12-month high of $12.00. The company has a 50-day moving average of $3.30 and a 200 day moving average of $5.31.

Neonc Technologies (NASDAQ:NTHI) last issued its earnings results on Thursday, November 5th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.03).

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on NTHI shares. Zacks Research upgraded Neonc Technologies from a “strong sell” rating to a “hold” rating in a report on Thursday, November 5th. BTIG Research reissued a “buy” rating and set a $15.00 price objective on shares of Neonc Technologies in a research report on Tuesday, September 8th. Roth Capital assumed coverage on shares of Neonc Technologies in a research note on Thursday, September 24th. They set a “buy” rating on the stock. Wall Street Zen upgraded shares of Neonc Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, November 7th. Finally, Weiss Ratings cut shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, October 21st. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Neonc Technologies has a consensus rating of “Moderate Buy” and an average target price of $16.00.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of NTHI. Bank of America Corp DE increased its holdings in shares of Neonc Technologies by 5.0% in the first quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock valued at $1,650,000 after purchasing an additional 11,108 shares during the period. Westmount Partners LLC raised its position in Neonc Technologies by 355.2% during the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after buying an additional 153,858 shares during the last quarter. BlackRock Inc. purchased a new stake in shares of Neonc Technologies in the second quarter valued at about $815,000. Finally, Global Retirement Partners LLC purchased a new position in Neonc Technologies during the second quarter worth about $126,000.

Neonc Technologies Company Profile

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.